+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global External Ventricular Drain Market Report and Forecast 2023-2031

  • PDF Icon


  • 140 Pages
  • May 2023
  • Region: Global
  • Expert Market Research
  • ID: 5797935
The global external ventricular drain market value was USD 4.7 billion in 2022, driven by the increasing prevalence of neurodegenerative disorders across the globe. The market size is anticipated to grow at a CAGR of 7% during the forecast period of 2023-2031 to achieve a value of USD 8.6 billion by 2031.

External Ventricular Drain Introduction

External ventricular drain (EVD), also known as a ventriculostomy, is a medical device that is used to treat patients who have excess cerebrospinal fluid (CSF) in the brain. The device is used to drain the fluid and relieve pressure in the brain, which can be caused by a variety of conditions such as brain injury, hydrocephalus, or bleeding in the brain.

EVDs are typically inserted through a small hole in the skull, allowing a catheter to be passed into the ventricles of the brain. The device is then used to drain excess CSF and monitor intracranial pressure.

The market for EVDs is driven by an increasing incidence of traumatic brain injury and neurological disorders, as well as the growing demand for minimally invasive surgical procedures. The market is expected to continue to grow as new technologies are developed and the demand for neurosurgical procedures increase.

Key trends in the market include the development of new, minimally invasive EVD devices that are easier to use and have fewer complications, as well as the increasing use of EVDs in developing countries where there is a growing demand for neurosurgical services. Additionally, there is a growing trend towards the integration of EVDs with other neurosurgical technologies, such as neuroendoscopy and neurostimulation, to provide more comprehensive treatment options for patients.

External Ventricular Drain Market Scenario

External ventricular drain (EVD), also known as ventriculostomy, is a medical device that is used to manage increased intracranial pressure by draining cerebrospinal fluid (CSF) from the ventricles of the brain. It is a hollow tube that is placed through a hole drilled in the skull into the lateral ventricle, which is the main reservoir for CSF in the brain. EVD is a critical component of neurosurgical procedures, particularly in the management of patients with traumatic brain injuries, intracerebral hemorrhage, or hydrocephalus.

The global EVD market is driven by the increasing prevalence of neurodegenerative disorders and traumatic brain injuries, along with the growing geriatric population. The rise in demand for minimally invasive procedures and technological advancements in EVD devices, such as the development of portable and wireless EVD systems, is expected to further boost the market growth. However, the high cost associated with EVD devices and the availability of alternative treatment options may hinder market growth. The EVD market is expected to continue to grow, driven by increasing investments in research and development, expanding healthcare infrastructure, and rising awareness of neurosurgical procedures.

External Ventricular Drain Market Segmentations

Market Breakup by Product

  • Ventricular Drainage Set
  • Accessories

Market Breakup by Application

  • Hydrocephalus
  • Reye Syndrome
  • Subarachnoid Haemorrhage
  • Traumatic Brain Injury
  • Others

Market Breakup by End User

  • Hospitals
  • Specialty Hospitals
  • Specialty Clinics
  • Others

Market Breakup by Region

North America

  • United States of America
  • Canada


  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Key Trends in the External Ventricular Drain Market

The key trends in the market for External Ventricular Drain (EVD) include:

  • Technological advancements: Advancements in technology have led to the development of more efficient and reliable EVDs that allow for better patient outcomes
  • Rising incidence of neurological disorders: The increasing incidence of neurological disorders such as traumatic brain injury, stroke, and hydrocephalus is driving the demand for EVDs
  • Growing geriatric population: The elderly population is more susceptible to neurological disorders and requires medical devices such as EVDs for treatment
  • Increasing number of neurosurgery procedures: The rising number of neurosurgery procedures has led to an increase in the demand for EVDs in hospitals and clinics
  • Improving healthcare infrastructure: The development of healthcare infrastructure in emerging economies has increased access to medical devices such as EVDs, driving market growth
  • Rising awareness about neurological disorders: The growing awareness about neurological disorders and the availability of treatment options, including EVDs, is increasing demand for the devices
Overall, the EVD market is expected to grow in the coming years, driven by the increasing demand for neurological treatments and advancements in technology.

External Ventricular Drain Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Medtronic plc
  • Integra Life Sciences Corporation
  • Spiegelberg GmbH & Co. KG
  • Zebra Medical
  • Neuromedex GmbH

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global External Ventricular Drain Market Overview
3.1 Global External Ventricular Drain Market Historical Value (2016-2022)
3.2 Global External Ventricular Drain Market Forecast Value (2023-2031)
4 Global External Ventricular Drain Market Landscape
4.1 Global External Ventricular Drain Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global External Ventricular Drain Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Application
4.2.3 Analysis by End User
5 Global External Ventricular Drain Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global External Ventricular Drain Market Segmentation
6.1 Global External Ventricular Drain Market by Product
6.1.1 Market Overview
6.1.2 Ventricular Drainage Set
6.1.3 Accessories
6.2 Global External Ventricular Drain Market by Application
6.2.1 Market Overview
6.2.2 Hydrocephalus
6.2.3 Reye Syndrome
6.2.4 Subarachnoid Haemorrhage
6.2.5 Traumatic Brain Injury
6.2.6 Others
6.3 Global External Ventricular Drain Market by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Specialty Hospitals
6.3.4 Specialty Clinics
6.3.5 Others
6.4 Global External Ventricular Drain Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America External Ventricular Drain Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe External Ventricular Drain Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific External Ventricular Drain Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.6 Australia
9.7 Others
10 Latin America External Ventricular Drain Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa External Ventricular Drain Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.5 Others
17 Supplier Landscape
17.1 Medtronic plc
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Integra Life Sciences Corporation
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Spiegelberg GmbH & Co. KG
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Zebra Medical
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Neuromedex GmbH
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
18 Global External Ventricular Drain Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Medtronic plc
  • Integra Life Sciences Corporation
  • Spiegelberg GmbH & Co. Kg
  • Zebra Medical
  • Neuromedex GmbH
  • Sophysa
  • Dispomedica GmbH
  • Möller Medical GmbH
  • Fuji Systems
  • B. Braun Melsungen Ag



Table Information